Recent advances in the design of small molecular drugs with acrylamides covalent warheads

被引:2
|
作者
Liang, Luxia [1 ,2 ,3 ]
Zhang, Ze [1 ,2 ,3 ]
You, Qidong [1 ,2 ,3 ]
Guo, Xiaoke [1 ,2 ,3 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Peoples R China
[3] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing 210009, Peoples R China
基金
中国国家自然科学基金;
关键词
Acrylamide; Covalent warhead; Small molecular drug; Inhibitors; GROWTH-FACTOR RECEPTOR; BRUTONS TYROSINE KINASE; IRREVERSIBLE INHIBITORS; JAK3; INHIBITORS; DISCOVERY; CANCER; INACTIVATION; QUINAZOLINE; REACTIVITY; STRATEGY;
D O I
10.1016/j.bmc.2024.117902
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the development of covalent inhibitors, acrylamides warhead is one of the most popular classes of covalent warheads. In recent years, researchers have made different structural modifications to acrylamides warheads, resulting in the creation of fluorinated acrylamide warheads and cyano acrylamide warheads. These new warheads exhibit superior selectivity, intracellular accumulation, and pharmacokinetic properties. Additionally, although ketoamide warheads have been applied in the design of covalent inhibitors for viral proteins, it has not received sufficient attention. Combined with the studies in kinase inhibitors and antiviral drugs, this review presents the structural features and the progression of acrylamides warheads, offering a perspective on future research and development in this field.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinoma
    Almeida, Madson Q.
    Hoff, Ana O.
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 229 - 234
  • [22] Recent Advances in the Development of Hybrid Drugs
    Morais, Tania S.
    PHARMACEUTICS, 2024, 16 (07)
  • [23] Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions
    Thakur, Amandeep
    Rana, Mandeep
    Mishra, Anshul
    Kaur, Charanjit
    Pan, Chun-Hsu
    Nepali, Kunal
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 272
  • [24] Recent Advances and Perspectives in Cancer Drug Design
    Magalhaes, Luma G.
    Ferreira, Leonardo L. G.
    Andricopulo, Adriano D.
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2018, 90 : 1233 - 1250
  • [25] Recent Advances in Small Molecule PROTACs for the Treatment of Cancer
    Li, Wen
    Elhassan, Reham M.
    Hou, Xuben
    Fang, Hao
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (24) : 4893 - 4909
  • [26] Recent Advances in Small Molecule Inhibitors for the Treatment of Osteoarthritis
    Lin, Jianjing
    Jia, Shicheng
    Zhang, Weifei
    Nian, Mengyuan
    Liu, Peng
    Yang, Li
    Zuo, Jianwei
    Li, Wei
    Zeng, Hui
    Zhang, Xintao
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [27] Recent advances in small molecule based cancer immunotherapy
    Cheng, Binbin
    Yuan, Wei-En
    Su, Jing
    Liu, Yao
    Chen, Jianjun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 582 - 598
  • [28] Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review
    Borthwick, Alan D.
    Goncalves, Maria B.
    Corcoran, Jonathan P. T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (20)
  • [29] Recent Advances in Molecular Recognition Based on Nanoengineered Platforms
    Mu, Bin
    Zhang, Jingqing
    McNicholas, Thomas P.
    Reuel, Nigel F.
    Kruss, Sebastian
    Strano, Michael S.
    ACCOUNTS OF CHEMICAL RESEARCH, 2014, 47 (04) : 979 - 988
  • [30] Insights to Design New Drugs against Human African Trypanosomiasis Targeting Rhodesain using Covalent Docking, Molecular Dynamics Simulations, and MM-PBSA Calculations
    Nascimento, Igor Jose dos Santos
    Santos, Mirelly Barbosa
    Marinho, Washley Phyama De Jesus
    de Moura, Ricardo Olimpio
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2025, 21 (01) : 67 - 82